Search

everythinglearnresearchcommunity

for

Search:↓

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Cancer treatments often cause skin, nail, and hair problems.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Maslinic acid from olive extracts promotes hair growth like minoxidil.

Baricitinib works better than methotrexate for severe alopecia areata.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

EGFR inhibitors for lung cancer can cause severe skin issues.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

The new nanoparticles could improve melanoma treatment by working better than current options.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Reducing gefitinib dosage improved hair loss, but scarring remained.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.